Kipk...so would you say that Apabetalone is on the right track.
"According to the studies, apabetalone can potentially target SARS-CoV-2 with a peculiar dual-mechanism of preventing viral entry to cells and its replication, and by stopping runaway inflammatory reactions."
Koo